Drugs
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 14.7 | Q1 | 99.1% | 3.500 | Q1 | 98.2% |
| 2024 | 14.4 | Q1 | 100.0% | 3.362 | Q1 | 98.1% |
| 2023 | 13.0 | Q1 | 100.0% | 2.352 | Q1 | 96.6% |
| 2022 | 11.5 | Q1 | 99.0% | 2.093 | Q1 | 96.1% |
| 2021 | 11.4 | Q1 | 99.0% | 2.081 | Q1 | 96.2% |
| 2020 | — | — | 2.022 | Q1 | 95.7% | |
| 2019 | — | — | 1.589 | Q1 | 93.3% | |
| 2018 | — | — | 1.527 | Q1 | 92.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1179-1950
ISSN
0012-6667
country
CHcoverage
1971-2026